MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia = Metilasi promoter MGMT dan SPOCK2 dalam diffuse large B-cell lymphoma: satu kajian yang dijalankan di dua pusat Kesihatan di Pantai Timur Malaysia

QR Code

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia = Metilasi promoter MGMT dan SPOCK2 dalam diffuse large B-cell lymphoma: satu kajian yang dijalankan di dua pusat Kesihatan di Pantai Timur Malaysia

MGMT (O6-Methylguanine-DNA Methyltransferase) suppresses tumor development by removing alkyl adduct, while SPOCK2 (SPARC/Osteonectin CWCV and Kazal-like domains proteoglycan) abolishes the inhibition of membrane-type matrix metalloproteinases (MT-MMP) which leads to angiogenesis. Hence, MGMT methyla...

Full description

Bibliographic Details
Main Authors:	Zainuddin, Norafiza, Mohd. Ridah, Lailatul Jalilah, Omar, Aqilah Nabihah, A. Talib, Norlelawati, Muhammad, Siti Aeshah @ Naznin, Hussain, Faezahtul Arbaeyah
Format:	Article
Language:	English
Published:	Universiti Kebangsaan Malaysia 2017
Subjects:	RB Pathology RC254 Neoplasms. Tumors. Oncology (including Cancer)
Online Access:	http://irep.iium.edu.my/56529/ http://irep.iium.edu.my/56529/1/56529_MGMT%20and%20SPOCK2%20Promoter%20Methylation.pdf

Similar Items

Methylation status of MGMT and SPOCK2 in diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2016)

Epigenetic methylation status of P16, MGMT and SPOCK2 in diffuse Large B cell lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

Methylation-specific PCR Revealed Aberrant Promoter Gene Methylation of p16, MGMT and SPOCK2 in Diffuse Large B-cell Lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2015)

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia
by: Norafiza Zainuddin,, et al.
Published: (2017)

Epigenetic silencing status of p16INK4a and MGMT promoter regions identified qualitatively in diffuse large B cell lymphoma
by: Mohd Ridah, L Jalilah, et al.
Published: (2015)

Detection of p16INK4a (p16) methylation in diffuse large B-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

p16 tumor suppressor gene methylation in diffuse large B cell lymphoma: a study of 88 cases at two hospitals in the east coast of Malaysia
by: Mohd Ridah, Lailatul Jalilah, et al.
Published: (2017)

Pyrosequencing-based quantitative identification of p16 methylation in diffuse large B-cell lymphoma at two centres in the East Coast of Malaysia
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration.
by: Shamsudin, Norashikin, et al.
Published: (2012)

Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016)

The immunohistochemical studies of double or triple protein lymphoma in diffuse large B-cell lymphoma and their correlation with clinicopathological parameters
by: Wahab, Wan Nor Najmiyah Wan Abdul
Published: (2017)

Qualitative detection of p16INK4a tumor suppressor gene methylation in diffuse large b-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases
by: Boyle, Terry, et al.
Published: (2017)

Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2011)

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
by: Hedstrom, Gustav, et al.
Published: (2014)

Diffuse large B-cell lymphoma of the small intestine in a patient with refractory coeliac disease.
by: Ahmad Affandi, Khairunisa, et al.
Published: (2019)

Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma
by: Keng, Wong Kah
Published: (2018)

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
by: Zainuddin, Norafiza, et al.
Published: (2008)

Patched-1 and smoothened, a hedgehog receptor and signal transducer are highly expressed in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina, et al.
Published: (2017)

Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas
by: Hirpara, J., et al.
Published: (2016)

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
by: Morin, R., et al.
Published: (2010)

The Role Of 18F -FDG PET-CT In Assessing Bone Marrow Involvement In Diffuse Large B-Cell Lymphoma (DLBCL)
by: Nasir, Siti Maisarah Mohd
Published: (2018)

Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
by: Ahmad, Aliza, et al.
Published: (2022)

Primary cutaneous anaplastic large cell lymphoma with lung metastasis
by: Esa, Nor Kamaruzaman, et al.
Published: (2016)

Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
by: Dang, Chee Chean
Published: (2018)

The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015
by: Yong, Teh Chee
Published: (2017)

Involvement of the P53 pathway and P161NK4A in the pathogenesis of b-cell lymphomas
by: Zainuddin, Norafiza
Published: (2011)

Group- based quantitative structural activity relationship analysis of B-cell Lymphoma Extra Large (BCL-XL) inhibitors
by: Abdul Samat, Nadia Hanis, et al.
Published: (2014)

Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99
by: Mohd Sidik, Shiran, et al.
Published: (2008)

Temozolomide analog PMX 465 downregulates MGMT expression in HCT116 colorectal carcinoma cells
by: Yang, Zhikuan, et al.
Published: (2018)

Molecular genetic analysis in B-cell Lymphomas : a focus on the p53 pathway and p16INK4a
by: Zainuddin, Norafiza
Published: (2010)

Anaplastic large cell lymphoma presenting as a soft tissue mass – A case report
by: Siti-Aishah M.A.,, et al.
Published: (2008)

The expression of IL-21 is promoted by MEKK4 in malignant T cells and associated with increased progression risk in cutaneous T-cell lymphoma
by: Fredholm, Simon, et al.
Published: (2016)

Mantle Cell Lymphoma Masquerading as obstructive sleep apnoea
by: Ishak, Noor Liza, et al.
Published: (2022)

Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines
by: Ikeda, Jun-ichiro, et al.
Published: (2010)

The novel role of the B-cell lymphoma/leukemia 11A (BCL11A) gene in β-thalassaemia treatment
by: Lai, Mei I, et al.
Published: (2023)

Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
by: Krejsgaard, Thorbjørn, et al.
Published: (2016)

The evaluation of 06-methylguanine-DNA-methyltransferase (MGMT) gene methylation status among Hospital Universiti Sains Malaysia glioma patients
by: Murali, Revathy
Published: (2018)

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
by: Ikeda, Jun-ichiro, et al.
Published: (2012)

Angioimmunoblastic T-cell lymphoma (AITL): a rare entity, commonly misdiagnosed
by: Seman, Zainina, et al.
Published: (2024)